Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.
Clinical trial NCT00775138 · COMPLETED
Trial details
- NCT number
- NCT00775138
- Sponsor
- Insmed Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-24
- Primary completion
- 2009-05-11
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.